VIVA 2022: Don't Roll the Dice with Ca++ Modification

Join us in Las Vegas for VIVA 2022 as we crack into late breaking data supporting IVL’s consistency in calcium modification in real-world PAD. The late breaker, presented by Dr. Ehrin Armstrong, features the final 1,373 patient cohort data from the Disrupt PAD III Observational Study. Following the data release, an esteemed panel will discuss IVL’s consistent outcomes from both real-world AND randomized studies. Don’t roll the dice with calcium modification and join us at VIVA 2022!


Late Breaking Trial

Intravascular Lithotripsy for the Treatment of Peripheral Artery Calcification: Results from the Disrupt PAD III Observational Study 

Tuesday, November 1st 11:45am PT





IVL’s Consistency in Randomized & Real-World Studies 

Tuesday, November 1st 12pm - 1:10pm PT





See the full IVL lineup in the eFlyer below:



VIVA2022 eflyer_SPL 67404_Rev A-image










To download the full eFlyer, click here




For real-time Shockwave IVL news & activities at VIVA 2022, follow @ShockwaveIVL on Twitter!



All physicians are paid consultants of Shockwave Medical.


Important Safety Information


In the United States: Rx only.


Indications for Use—The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Not for use in the coronary or cerebral vasculature.


Contraindications—Do not use if unable to pass 0.014 guidewire across the lesion—Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.


Warnings—Only to be used by physicians who are familiar with interventional vascular procedures—Physicians must be trained prior to use of the device—Use the generator in accordance with recommended settings as
stated in the Operator’s Manual.


Precautions—use only the recommended balloon inflation medium—Appropriate anticoagulant therapy should be administered by the physician—Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology.

Adverse effects–Possible adverse effects consistent with standard angioplasty include – Access site complications – Allergy to contrast or blood thinner – Arterial bypass surgery — Bleeding complications — Death — Fracture of guidewire or device — Hypertension/Hypotension — Infection/sepsis — Placement of a stent — renal failure — Shock/pulmonary edema — target vessel stenosis or occlusion — Vascular complications. Risks unique to the device and its use — Allergy to catheter material(s) — Device malfunction or failure — Excess heat at target site.


Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.


Please contact your local Shockwave representative for specific country availability and refer to the Shockwave S4, Shockwave M5, and Shockwave M5+ instructions for use containing important safety information.


true false VIVA 2022: Don't Roll the Dice with Ca++ Modification Click Here To View

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.